Vol 10, No 1 (2024)

Cover and Contents

Cover and Content	PDF
	1-4

Original Article

Extension of therapeutic indication and marketing authorization refusal – key aspects in EMA procedures during the period 2022-2024	PDF
Violeta Getova-Kolarova, Ines Hababa-Ivanova, Antonio Ivanov, Ilko Getov	5-11

Reimbursement of biomarkers in oncology: advantages and economic analysis of their application for diagnostics as part of the personalized medicine аpproach	PDF
Veneta Todorova, Emilia Krapcheva, Georgi Slavchev, Slaveyko Dzhambazov, Toni Vekov	12-22

The role of medicinal products and medical devices classification systems in patient therapy management in hospitals	PDF
Anita Neeva, Paola Petkova-Slavcheva, Evgeni Grigorov	23-29

Overview of the historical development and analysis of the stages of introduction of clinical pharmacy in Bulgaria	PDF
Savina Elitova, Ilko Getov	30-37

Review Article

The role of the hospital pharmacist in optimizing therapy in patients with chronic myeloid leukemia	PDF
Natalia Kokudeva, Violeta Getova-Kolarova, Emil Aleksov, Maria Kamusheva, Ilko Getov	38-46

A review of the fundamental principles for personalized pharmacotherapy prescribing for patients with concurrent renal and cardiac failure: the hospital pharmacist’s perspective	PDF
Svetoslav Stoev, Hristina Lebanova	47-55

Main approaches for systemic treatment of unresectable malignant pleural mesothelioma	PDF
Krum Kafedjiiski	56-64

Review of the economic burden of metastatic prostate cancer	PDF
Konstantin Ivanov, Hristina Lebanova	65-71

Pharmacotherapy of non-small cell lung cancer with EGFR activating mutations using tyrosine kinase inhibitors: the role of hospital pharmacists in preventing drug-drug interactions in this class of medicines	PDF
Ivanka Mutafova	72-89

Pharmacotherapy treatment options for advanced heart failure: a review	PDF
Antoniya Kisheva, Mesut Rushid, Tanya Ivanowa, Tatyana Chalykova, Aylin Hadjiveli	90-93